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Abstract
Though widely employed for clinical intervention in obesity, metabolic syndrome, seizure disorders and other
neurodegenerative diseases, the mechanisms through which low carbohydrate ketogenic diets exert their
ameliorative effects still remain to be elucidated. Rodent models have been used to identify the metabolic and
physiologic alterations provoked by ketogenic diets. A commonly used rodent ketogenic diet (Bio-Serv F3666) that is
very high in fat (~94% kcal), very low in carbohydrate (~1% kcal), low in protein (~5% kcal), and choline restricted
(~300 mg/kg) provokes robust ketosis and weight loss in mice, but through unknown mechanisms, also causes
significant hepatic steatosis, inflammation, and cellular injury. To understand the independent and synergistic roles of
protein restriction and choline deficiency on the pleiotropic effects of rodent ketogenic diets, we studied four custom
diets that differ only in protein (5% kcal vs. 10% kcal) and choline contents (300 mg/kg vs. 5 g/kg). C57BL/6J mice
maintained on the two 5% kcal protein diets induced the most significant ketoses, which was only partially diminished
by choline replacement. Choline restriction in the setting of 10% kcal protein also caused moderate ketosis and
hepatic fat accumulation, which were again attenuated when choline was replete. Key effects of the 5% kcal protein
diet – weight loss, hepatic fat accumulation, and mitochondrial ultrastructural disarray and bioenergetic dysfunction –
were mitigated by choline repletion. These studies indicate that synergistic effects of protein restriction and choline
deficiency influence integrated metabolism and hepatic pathology in mice when nutritional fat content is very high,
and support the consideration of dietary choline content in ketogenic diet studies in rodents to limit hepatic
mitochondrial dysfunction and fat accumulation.
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Introduction
Ketogenic diets confer a multitude of beneficial effects on
health in experimental and clinical settings, including weight
loss in obesity and the amelioration of metabolic syndrome
[1–5], anticonvulsant activity [6,7], autism [8],
neurodegenerative diseases including Parkinson’s and
Alzheimer’s [9–11], cardiomyopathy [12], and they show
promise as potential adjunctive therapy for cancers [13,14].
However, the mechanisms through which ketogenic diets
transduce their pleiotropic effects, and the long-term
physiological and metabolic alterations that may occur during
adherence to ketogenic diets, are incompletely understood. In
particular, it is not clear whether beneficial effects of ketogenic
diets are related to the generation and/or metabolism of ketone
bodies, or whether the low carbohydrate content itself supports
a salutary metabolic and/or endocrine milieu [7]. Rodents have
been used extensively to determine the physiological and
metabolic responses to ketogenic diets [15–21]. However,
because diet-induced ketonemia in rodents requires marked
diminution of both carbohydrates and protein content, truly
ketogenic diets for rodents consist of a macronutrient balance
that humans do not ingest [22]. A widely used
[8,12,15,16,18–21,23–25] micronutrient-supplemented
ketogenic diet for rodents, Bio-Serv F3666, is very high in fat
(93.3% kcal), very low in carbohydrate (1.8%), and relatively
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depleted of protein (4.7%). This diet provokes ketonemia,
weight loss, and induces a hepatic gene expression signature
consistent with decreased de novo lipogenesis and increased
fatty acid oxidation [15,16]. C57BL/6J mice maintained on this
ketogenic diet become lean, euglycemic, ketotic,
hypoinsulinemic, and glucose intolerant [15,21]. Additionally,
mice fed this ketogenic diet exhibit a distinctive nonalcoholic
fatty liver disease (NAFLD) profile including micro- and
macrovesicular steatosis with hepatocellular injury and repair.
The macronutrient composition that induces this histological
signature is atypical for human NAFLD, which is commonly
associated with increased carbohydrate intake and activated
de novo lipogenesis [16,26,27]. In fact, low carbohydrate diets
in humans may improve NAFLD [26–28].
To establish safe and effective therapeutic nutritional
approaches for diseases that may be responsive to low-
carbohydrate diets, it will ultimately be important to understand
the driver mechanisms responsible for favorable responses,
and whether these responses and their underlying mechanisms
can be nutritionally dissociated from concomitantly-triggered
pathophysiological responses. A potential contributor to the
liver fat accumulation and injury that are provoked by Bio-Serv
F3666 [16,21], despite its salutary effects in other organ
systems [8,12,20], is protein restriction. In fact, Bio-Serv F3666
diet may mimic a subset of the systemic and hepatic sequelae
of malnutrition attributable to very low protein ingestion in
human patients with kwashiorkor [29]. An additional
prospective explanation is the influence of choline restriction
[30]. While fully replete rodent diets are supplemented to
contain ≥ 2 g/kg choline, Bio-Serv F3666 is not supplemented,
and therefore contains only ~300 mg/kg from naturally-derived
fat sources. In this study, we examined the roles of dietary
protein and choline contents on the systemic and hepatic
derangements that occur in the setting of very high fat, very low
carbohydrate diets. Using Bio-Serv F3666 as a reference diet,
we designed a very low carbohydrate, very low protein, and
choline restricted (VLP/C-) diet and three additional diets which
differ only in total protein [10% kcal (low protein, LP) vs. 5%
kcal (very low protein, VLP)] and choline content [replete (C+)
vs. restricted (C-)] to elucidate the contributing mechanistic
roles of each component in the onset and progression of the
hepatic pathology observed in ketogenic diet-fed mice.
Table 1. Macronutrient composition of mouse diets used in this study.
Diet
Vendor (Catalog
Number) Carb % kcal Fat % kcal
Protein %
kcal






Standard Chow Lab Diet (5053) 62.1 13.2 24.6 2.0 (N/A) 7.0 (N/A) 141 3.4
LP/C+ Harlan Teklad (110291) 1.4 88.9 9.7 5.3 (0%) 7.4 (0%) 2500 7.3
LP/C- Harlan Teklad (110406) 1.4 89.0 9.6 0.3 (88%) 4.4 (37%) 2500 7.2
VLP/C+ Harlan Teklad (110634) 1.3 94.1 4.6 5.3 (0%) 3.7 (47%) 2500 7.6
VLP/C- Harlan Teklad (110633) 1.3 94.1 4.6 0.3 (>90%*) 2.2 (82%*) 2500 7.6
All diets are irradiated (to sterilize) before feeding. Values represent percentage of total kcal. Choline added to diets as choline chloride (Lab Diet) or choline bitartrate
(Harlan Teklad). Methionine content is calculated based on the amino acid composition of casein, plus additional elemental methionine (for VLP/C+ and LP/C+). * Corrected
for diminished mass of diet consumed.
doi: 10.1371/journal.pone.0074806.t001
Table 2. Serum parameters after 6 weeks on diets.
Diet βOHB, mM Glucose, mg/dL Insulin, ng/mL HOMA-IR FFA, mM TAG, mg/dL
Standard Chow 0.10±0.03 121.6±3.7 1.10±0.14 8.2±1.1 1.24±0.10 70.3±4.5
LP/C+ 0.44±0.03a 212.2±15.2aa 0.90±0.16 11.7±2.4 0.36±0.08aaa 67.3±3.1
LP/C- 0.60±0.08a 175.8±11.6a 0.70±0.10 8.6±1.8 0.30±0.06 aaa 57.3±3.8
VLP/C+ 0.80±0.11a,b 172.5±8.9a 0.62±0.12 7.1±1.5 0.48±0.06 aaa 85.7±8.5
VLP/C- 1.46±0.34aaa,bb 119.0±15.8b,c 0.37±0.04 aa,b 2.9±0.5a,b 0.64±0.05 aaa,b 95.0±10.7 bb
HOMA-IR, homeostatic model assessment of insulin resistance
FFA, non-esterified(free) fatty acids
TAG, triacylglycerols
a p≤0.05, aa p≤0.01, aaa p≤0.001 (one-way ANOVA) compared to chow
b p≤0.05, bb p≤0.01 (one-way ANOVA) attributable to decrease in protein content (from 10% kcal to 5% kcal) at a fixed choline content
c p≤0.05 (one-way ANOVA) attributable to restriction in choline content (from 5.3 g/kg to 0.3 g/kg) at 5% kcal protein
doi: 10.1371/journal.pone.0074806.t002
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Methods
Animals and diets
C57BL/6J wild-type mice were maintained on Lab Diet
(5053) ad libitum and autoclaved water on cedar chip bedding
at 22°C. Lights were off between 1800 and 0600. Beginning at
the age of 6 weeks male mice were maintained for 6 weeks on
one of the following very high fat, very low carbohydrate
(ketogenic) paste diets, whose contents are summarized in
Table 1: 1) low protein, choline replete (LP/C+, Harlan-Teklad
TD.110291), 2) low protein, choline restricted (LP/C-, Harlan-
Teklad TD.110406), 3) very low protein, choline replete (VLP/C
+, Harlan-Teklad TD.110634), or 4) very low protein, choline
restricted (VLP/C-, Harlan-Teklad TD.110633). Diets were
sterilized prior to shipment, stored at 4°C, and administered
every 2-3 days in autoclaved glass dishes on the cage
bottoms. Consumption of diets was determined between weeks
2 and 4 of the administration period, and was performed by
weighing paste diet mass prior to and after 48 h of feeding.
Age-matched cohorts of mice were maintained on the standard
low-fat, polysaccharide-rich chow pellets (Lab Diet 5053) to
serve as controls. Consistent with the historically-used Bio-
Serv F3666 diet, the contributing fat sources of all four
ketogenic diets are lard and milk fat; casein is the protein
source, and sucrose is the minimal carbohydrate source (~1%
kcal). All diets were supplemented with vitamin mix AIN-76 and
mineral mix AIN-76A. The distribution of fatty acids among all
four diets is similar, with 46-52% originating from saturated,
38-41% from monounsaturated, and 7-17% from
polyunsaturated fatty acids. Choline replete diets are
supplemented with 5.0 g/kg supplied as choline bitartrate. All
four diets are soy meal (phytoestrogen) free. All experiments
were performed after protocol approval by the Animal Studies
Committee at Washington University.
Metabolite and insulin measurements
Serum samples were acquired from animals that had been
fasted for 4 h on fresh cedar chip bedding. Serum glucose, free
fatty acids (FFA), β-hydroxybutyrate (βOHB), triacylglycerols
(TAG), and insulin concentrations were measured as
previously described [18]. Hepatic TAG, using a Folch extract
of liver and biochemical quantification, were quantified as
previously described [24]. Serum alanine aminotransferase
Figure 1.  Metabolic parameters of mice maintained on very high fat, low protein, very low carbohydrate diets.  (A) Body
weight responses to 6 weeks of maintenance on the experimental paste diets, compared to chow controls. n=10-15 mice/group. a,
p≤0.001; b, p≤0.001; c, p≤0.01. See end of this legend for description of the individual comparisons depicted by each letter. (B)
Caloric consumption of diet, normalized per mouse, between weeks two and four of the 6 weeks of maintenance on the diets.
n=5-10 mice/group. a, p≤0.001; c, p≤0.05. (C) Caloric consumption of diet, normalized per gram of body weight (BW). n=5-10 mice/
group. a, p≤0.001; b, p≤0.01. (D) Percent adiposity after 6 weeks on each of the diets. n=5-10 mice/group. a, p≤0.01; c, p≤0.05. For
all panels, data are presented as means±SEM. a, significantly different compared to chow; b, significant difference attributable to
decrease in protein content (from 10% kcal to 5% kcal) at a fixed choline content; c, significant difference attributable to restriction in
choline content (from 5.3 g/kg to 0.3 g/kg) at a fixed protein content; by 1-way ANOVA with Tukey’s post hoc testing.
doi: 10.1371/journal.pone.0074806.g001
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Figure 2.  Roles of varying protein and choline nutrient
contents in very high fat, low protein, very low
carbohydrate diet-induced hepatic steatosis.  (A) Liver
weight/body weight ratios after 6 weeks on the diets. n=5-10
mice/group. c, p≤0.05 for LP/C- and p≤0.01 for VLP/C-. See
end of this legend for description of the individual comparisons
depicted by each letter. (B) Biochemical quantification of
hepatic TAG content, normalized to liver mass. n=5-10 mice/
group. a, p≤0.05 for LP/C- and p≤0.01 for VLP/C-; b, p≤0.05; c,
p≤0.05 for LP/C- and p≤0.01 for VLP/C-. (C) Serum alanine
aminotransferase (ALT) concentrations. n=4-6 mice/group. c,
p≤0.05. Data are presented as means±SEM. a, significant
difference compared to chow; b, significant difference
attributable to decrease in protein content (from 10% kcal to
5% kcal) at a fixed choline content; c, significant difference
attributable to restriction in choline content (from 5.3 g/kg to 0.3
g/kg) at a fixed protein content; by 1-way ANOVA with Tukey’s
post hoc testing.
doi: 10.1371/journal.pone.0074806.g002
(ALT) was measured using an assay from Teco Diagnostics,
according to manufacturer’s instructions.
Measurements of body composition
Percent body fat was determined in awake animals using an
EchoMRI instrument (Echo Medical Systems, Houston, TX).
Histology
For hematoxylin and eosin stains, livers (n=3 separate
specimens from three different animals/diet condition) were
collected from mice immediately post-sacrifice and fixed in 10%
neutral buffered formalin. Tissue was embedded in paraffin,
microtome-sectioned, stained, imaged; low power images were
photographed using standard methods, while higher power
images were acquired at 0.5 μm slice thickness using a Zeiss
LSM 700 confocal microscope and Zeiss Zen software. For
F4/80 immunostains (n=3 stained sections, derived from three
separate animals/diet condition), rat anti-F4/80 (Abcam,
Cambridge MA) was incubated for 1 h at room temperature on
liver cryosections (diluted 1:100 in 5% bovine serum albumin
(BSA) in phosphate buffered saline (PBS), followed by Alexa
Fluor 594 conjugated goat anti-rat IgG (Invitrogen, 1:300 in 5%
BSA/PBS), and counterstained with 4',6-diamidino-2-
phenylindole (DAPI, 40 ng/mL in PBS for 5 min) as previously
described [16]. All slides were examined and images were
acquired at 0.5 μm slice thickness using a Zeiss LSM 700
confocal microscope and Zeiss Zen software. Using ImageJ,
F4/80+ cells were quantified and normalized per 100 nuclei in
each field; on average 350 DAPI positive nuclei were quantified
in each 20X field.
Transmission electron microscopy (TEM)
Livers (n=2 separate specimens from two different animals/
diet condition) were fixed in a modified Karnovsky’s fixative of
3% glutaraldehyde and 1% paraformaldehyde in 0.1M sodium
cacodylate buffer for at least 24 h, followed by a post-fix in 2%
osmium tetroxide in 0.1 M sodium cacodylate buffer for 1 h
prior to en bloc staining with 2% aqueous uranyl acetate for 30
min, dehydration in graded ethanols and embedding in
PolyBed 812 (Polysciences, Hatfield,PA). Tissue blocks were
sectioned at 90 nm thickness, then stained with Venable’s lead
citrate and viewed with a JEOL model 1200EX electron
microscope. Digital images were acquired using the AMT
Advantage HR (Advanced Microscopy Techniques, Danvers,
MA) high definition charge-coupled device, 1.3 megapixel TEM
camera.
Measurements of hepatic very low density lipoprotein
(VLDL) secretion in vivo
Mice were fasted overnight on fresh cedar chip bedding with
free access to drinking water. The following morning, mice
were injected with 500 mg/kg Triton WR-1339 (tyloxapol,
Sigma) [31], and blood was collected at 0, 2, 4 and 6 h. To
measure hepatic VLDL secretion, serum TAG levels were
measured at each time point as described above.
Mitochondrial genome copy number. gDNA was isolated
from liver of mice on all diets using a DNeasy Blood & Tissue
Choline and Ketogenic-Diet Induced Fatty Liver
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Kit (Qiagen). Genome copy number was quantified using real-
time quantitative PCR using the ΔΔCt approach as described
[18], normalized using primers against nuclear Rpl32 (F: 5’-
CCTCTGGTGAAGCCCAAGATC; R: 5’-
TCTGGGTTTCCGCCAGTTT) and mitochondrial genome
primers against mt-Atp6 (F: 5’- GCCATTCCACTATGAGCTG;
R: 5’-GTTCCTTGTGGAAGGAAGTG); mt-Cox1 (F: 5’-
GACTCCTACCACCATCATTTC; R: 5’-
AGGTGGGTAGACTGTTCAT); mt-Cox3 (F: 5’-
GGATTCTTCTGAGCGTTCTATC; R: 5’-




Whole livers were excised, washed, and suspended in
mitochondrial isolation medium (MIM; 300 mM sucrose, 0.2
mM EDTA, 10 mM HEPES, pH 7.4) containing BSA (1 mg/mL).
Figure 3.  Intrahepatic triglyceride content and hepatic histopathology in mice fed very high fat, low protein, very low
carbohydrate diets.  Hepatic histology in mice maintained for 6 weeks on (A–C) standard chow; (D–F) LP/C+ diet, which caused
very small amounts of mixed large and small droplet steatosis in hepatocytes restricted to zone 2 (a representative example of zone
2 is displayed in panel F), and no inflammation; (G–I) LP/C- diet, which caused mixed large and small droplet macrovesicular
steatosis in a zone 2 distribution (a representative example of zone 2 is displayed in panel I); (J–L) VLP/C+ diet, which exhibited
small lipid droplets only at higher power; (M–O) VLP/C- diet, which caused diffuse steatosis that is predominantly small and
microvesicular with some macrovesicular droplets. Numerous clusters of inflammatory cells, some of which are likely associated
with necrotic hepatocytes, were observed. Livers of mice fed both VLP/C+ (P) and VLP/C- (Q) exhibit inflammatory foci (arrows). (R)
Only in livers from VLP/C--fed were mitotic figures observed (arrow). Scale bars: (A, B, D, E, G, H, J, K, M, N, lower power images
taken with standard light microscopy, original magnification at 10X or 20X), 100 μm; (C, F, I, L, O, higher power images taken with
confocal microscopy, original magnification at 80X), 10 μm; (P, Q, R, medium power images taken with standard light microscopy,
original magnification at 40X), 50 μm.
doi: 10.1371/journal.pone.0074806.g003
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The samples were rapidly homogenized on ice by using a
Glas-Col dounce homogenizer, and centrifuged at 600g for 10
min at 4°C. The resulting supernatant, which contained
mitochondria, was spun at 8,000g for 15 min at 4°C, the
supernatant discarded, the mitochondrial pellet resuspended in
10 mL of ice-cold MIM-BSA, and the sample centrifuged again
at 8,000g for 15 min at 4°C. The pellet was briefly washed in
ice-cold MIM and resuspended in 75 μL of ice-cold MIM (pH
7.2) per 100 mg of liver. Total protein was quantified by
Bradford assay (Bio-Rad). Respiration was quantified at 37°C
using a water-jacketed Clark Electrode (Hansatech
Instruments) under conditions described previously [32].
Briefly, 0.5 mg of mitochondria were added to 1 mL of
respiration buffer [125 mM KCl, 20 mM HEPES, 3 mM Mg-
acetate, 0.4 mM EGTA, 0.3 mM dithiothreitol (DTT), 5 mM
KH2PO4, 0.2% BSA, pH 7.1] containing one of four substrate
combinations: (i) 20 μM palmitoyl-L-carnitine and 5 mM malate,
(ii) 5 mM succinate and 10 μM rotenone, (iii) 100 μM
duroquinol and 10 μM rotenone, or (iv) 0.5 mM N,N,N′,N′-
Tetramethyl-p-phenylenediamine (TMPD), 2 mM ascorbate,
and 10 μM rotenone. Duroquinol was prepared using a method
previously described [33]. Briefly, duroquinone was reduced
using KBH4 under acidic pH and anoxic atmosphere. The
solubility of oxygen in the respiration buffer at 37°C was 235
nmol O2 per mL. Following measurement of basal (state 2)
respiration, ADP was added to the respiration chamber at a
concentration of 1 mM in respiration buffer, and maximal (state
3) respiration quantified. Thereafter, state 4 (F1F0 ATPase-
independent) respiration was measured by adding 1 μg/mL
oligomycin (Sigma) to inhibit ATP synthase. Mitochondrial
uncoupling was measured following the addition of 5 μM
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP)
where applicable.
Statistical analyses
Analyses were performed with GraphPad software (Prism,
San Diego, CA), using tests described within the text and figure
legends.
Results
Comparison of choline replete and choline restricted,
low- and very low protein diets on body composition
and baseline metabolic parameters
To determine the effects of choline and protein content on
systemic and hepatic metabolism in the setting of very high fat
(≥89% kcal), very low carbohydrate (~1% kcal) macronutrient
composition, cohorts of 6 week-old C57BL/6J mice, all with
mean starting weights between 20.0 and 21.0 g, were fed one
of four custom paste diets for 6 weeks, defined as (1) low
protein (~10% kcal), choline replete (LP/C+), (2) low protein,
choline restricted (LP/C-), (3) very low protein (~5% kcal),
choline replete (VLP/C+), and (4) very low protein, choline
restricted (VLP/C-), and we compared responses of these
groups of mice to a cohort maintained on standard chow (Table
1). The VLP/C- diet was formulated to replicate Bio-Serv
F3666, a diet that we and others previously studied because it
induces ketosis and weight loss in murine models
[8,12,15,16,18–21,23–25]. Bio-Serv F3666 also causes hepatic
steatosis, hepatocellular injury, and hepatic macrophage
accumulation in C57BL/6J wild-type mice [16].
As previously observed in mice maintained on Bio-Serv
F3666, but unlike mice maintained on standard chow or the
other three experimental diets, mice maintained on VLP/C- diet
for 6 weeks failed to gain weight (Figure 1A). While mice
maintained on VLP/C+ gained weight over the 6 week period,
the extent of weight gain was ~60% less than that of mice
maintained on standard chow, LP/C+, or LP/C-. Differences in
Figure 4.  Hepatic macrophage density in mice fed very high fat, low protein, very low carbohydrate diets.  (A) Confocal
images of F4/80+ macrophages (scale bars, 50 μm) and (B) quantification of F4/80+ macrophages normalized to the number of
DAPI-stained nuclei from liver sections of mice maintained on the indicated diets for 6 weeks. Data are presented as means±SEM.
n=3 mice/group with n=3 20X fields quantified per section/mouse.
doi: 10.1371/journal.pone.0074806.g004
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weight gain between VLP/C+ and VLP/C- fed cohorts may be
partially attributable to diminished caloric consumption by mice
fed VLP/C- (Figure 1B), but normalizing caloric consumption to
body weight revealed no differences between these two diet
cohorts (Figure 1C). Independent of whether caloric
consumption was normalized per animal or to body mass,
caloric intake was increased in all cohorts of mice fed these
paste diets, compared to chow-fed mice. Together, these
observations are consistent with increased energy expenditure
of mice maintained on these very high fat diets (compared to
standard chow), which was observed in studies of mice
maintained on Bio-Serv F3666 [15,21]. Irrespective of choline
content, LP diet-ingesting cohorts both gained significantly
more weight than mice in the VLP-ingesting cohorts, indicating
that increased protein content of these two diets supports
weight gain [34]. Percent adiposity, measured by MRI, was
commensurate with the chow-fed cohort for mice maintained
Figure 5.  Hepatic TAG secretion in mice fed very high fat,
low protein, very low carbohydrate diets.  Mice from each
dietary group (6 weeks each diet) were fasted for 18 h. Blood
was collected prior to (0 h) and after intraperitoneal injection of
tyloxapol. (A) Serum TAG concentration and (B) areas under
the curve (AUC), n=5 mice/group. Data are presented as
means±SEM. a, significantly different compared to chow,
p≤0.001 by 1-way ANOVA with Tukey’s post hoc testing.
doi: 10.1371/journal.pone.0074806.g005
on LP/C-, VLP/C+, and VLP/C- (Figure 1D), while mice fed LP/C
+ displayed a significant increase in adiposity relative to the
other cohorts.
Compared to the chow-fed cohort, whose serum βOHB
concentrations were 0.10±0.03 mM, all groups of mice fed the
experimental diets for 6 weeks developed statistically
significant ketosis (Table 2). Mice maintained on VLP/C-
exhibited the highest βOHB mean serum concentration,
1.46±0.34 mM (n=10). Increasing protein content had a
modestly stronger suppressive effect on ketosis than
replenishing choline: mice maintained on LP/C- exhibited serum
βOHB concentrations that were 2.4-fold lower compared to
VLP/C--fed mice (0.60+0.08 mM in LP/C- mice; p=0.03
compared to the VLP/C- group, n=10/group), while the addition
of choline to VLP/C- (i.e., the VLP/C+ diet) decreased ketosis
only to 0.80±0.11 mM, which was not statistically different from
that induced by VLP/C-. The ketosis-suppressing effect of
increasing protein from 5% kcal to 10% kcal was also observed
when comparing the two choline-replete paste diets: while
serum βOHB concentrations were 0.80±0.11 mM in mice
maintained on VLP/C+, this decreased to 0.44±0.03 mM in mice
maintained on LP/C+ (p=0.006, n=10/group). Taken together,
the greatest degree of ketosis was observed in mice
maintained on VLP/C-, and the addition of choline to this diet
did not abrogate ketosis, as mice maintained on VLP/C+ display
an 8-fold elevation in serum βOHB concentrations compared to
chow-fed mice (p<0.0001, n=8-11/group).
Consistent with our previous findings in Bio-Serv F3666-fed
mice, VLP/C--fed mice exhibited 4 h-fasted serum glucose
levels commensurate with chow-fed animals, despite exhibiting
2.9-fold lower serum insulin concentrations (p<0.0001, n=5-10/
group) (Table 2) [16]. Conversely, LP/C+-, LP/C--, and VLP/C+-
fed mice each exhibited significantly elevated serum glucose
levels relative to both chow-fed and VLP/C--fed cohorts. Only
VLP/C--fed mice exhibited markedly diminished serum insulin
concentrations compared to those of chow-fed mice, which
accounts for the markedly decreased HOMA-IR index in this
cohort (2.9±0.5 vs. 8.2±1.1 in VLP/C- and chow-fed mice,
respectively, p=0.0003, n=5-10/group). Additionally HOMA-IR
indices of VLP/C--fed mice are significantly lower than those of
mice fed LP/C- (8.6±1.8, p=0.007, n=10/group). Circulating
non-esterified (free) fatty acids (FFA) were diminished in mice
fed each of the paste diets compared to chow-fed controls, and
these concentrations were inversely proportional to dietary
protein (Table 2). Likewise, circulating TAG concentrations
were inversely proportional to protein content, with less of an
effect derived from choline.
Effects of dietary choline and protein content on
hepatic steatosis and histopathology
To determine the effects of dietary protein and choline levels
on hepatic structure and function, we quantified hepatic mass
and intrahepatic triglyceride content after 6 weeks on each diet.
Mice fed either choline restricted diet (VLP/C- or LP/C-)
exhibited liver weight to body weight ratios that were ~25%
increased compared to mice fed the choline replete diets (LP/C
+ and VLP/C+) (Figure 2A). Additionally, normalized liver
weights of mice fed either choline replete paste diet were ~13%
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smaller compared to chow-fed mice. Hepatic TAG content in
mice maintained on VLP/C- (21.5±4.2 mg/g tissue) was
markedly higher than that of mice from any of the other paste
diet cohorts (Figure 2B). Hepatic TAG content in mice
maintained on the LP/C- diet was significantly higher than those
of mice maintained on LP/C+, VLP/C+, or chow control,
indicating that choline restriction in the context of a very high
fat diet predisposes to increased hepatic TAG content and that
this is exacerbated by severe protein limitation. Serum alanine
ALT activities were significantly elevated in both cohorts
maintained on the choline restricted diets, independent of
protein content (Figure 2C).
To determine the histopathological changes that accompany
hepatic lipid accumulation in mice maintained on these
ketogenic diets, liver sections from cohorts maintained on each
of the diets were stained with hematoxylin and eosin. Liver
sections from chow-fed animals displayed normal architecture
and were devoid of steatosis and inflammatory cell infiltration
(Figure 3A–C). Livers from mice maintained on LP/C+ exhibited
very small amounts of mixed large and small droplet steatosis
in hepatocytes located exclusively in acinar zone 2; periportal
and perivenular hepatocytes were virtually free of steatosis
(Figure 3D–F). Mice fed the choline-restricted counterpart,
LP/C-, displayed a marked increase in mixed large and small
droplet macrovesicular steatosis in a zone 2 distribution,
between the portal tracts and terminal hepatic venules (Figure
3G–I).
Low power images from livers from mice fed VLP/C+ were
unremarkable, with no signs of steatosis (Figure 3J-K), while
higher power images revealed scant small droplet steatosis in
hepatocytes in acinar zone 2 (Figure 3L). Conversely, livers
from mice maintained on VLP/C- diet displayed diffuse and
extensive steatosis (Figure 3M–O), primarily of small droplet
macrovesicular and microvesicular morphologies. Diffuse
activation of sinusoid-lining cells, characterized by increased
numbers of intrasinusoidal nuclei, and occasional acidophil
bodies were also noted, but no zonal necrosis was observed.
While differing markedly in hepatic lipid content, inflammatory
foci were readily observed in higher power images of hepatic
sections from both VLP/C+- and VLP/C--fed mice (Figure 3P-
Q). Mitotic figures, an additional sign of hepatocellular injury,
were observed uniquely in livers from VLP/C--fed mice (Figure
Figure 6.  Abnormal mitochondrial ultrastructure in mice fed a choline restricted, very high fat, low protein, very low
carbohydrate diet.  (A) Transmission electron micrograph of hepatocytes from mice maintained for 6 weeks on standard chow
reveals normal mitochondrial structure. Arrows, mitochondria. (B) Higher power image of mitochondria from mice maintained on
standard chow, demonstrating normal cristae. (C) Hepatocyte mitochondria from livers of mice maintained on VLP/C+ exhibited
normal cristae folding and evident double membranes. Sparse microvesicular lipid droplets were also evident (white circular
structure). Arrows, mitochondria; arrowhead; autophagosome. (D) Higher power image of hepatocyte mitochondria from mice
maintained on VLP/C+, showing morphology of the cristae. (E) VLP/C- diet induces massive hepatocyte steatosis (note large circular
pale fat droplets), and swollen mitochondria with disorganized and dilated cristae. Hepatocyte nucleus is on the right side of the
image. Arrows, mitochondria. (F) Higher power image of hepatocyte mitochondria from mice maintained on VLP/C-, with dilated
cristae (arrow) and an autophagosome (arrowhead). (G) High power image of hepatocyte mitochondria from mice maintained on
VLP/C-, with dilated cristae (arrows). Scale bars, 500 nm (A–F), 100 nm (G).
doi: 10.1371/journal.pone.0074806.g006
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3R). While immunostaining for F4/80+ macrophages revealed
modest differences in macrophage density (per total number of
cells observed), none of these differences was statistically
significant (Figure 4). Moreover, abundances of the mRNAs
encoding neither the macrophage marker CD68 nor the
inflammatory maker TNFα differed among the diets (data not
shown). While the total macrophage density trended lower in
mice fed VLP/C-, F4/80+ cell clusters were observed in livers
sections from VLP/C--fed mice, but not in hepatic sections from
mice fed the other diets (Figure 4A).
Very low carbohydrate/very high fat diets impair VLDL
secretion
Choline deficiency has been linked to impaired VLDL
packaging and secretion in the setting of high carbohydrate
diets [31]. Because choline is an essential nutrient required for
the formation of phosphatidylcholine (PC), and PC biosynthesis
is required for the formation of VLDL particles for egress of
TAG from the liver [35], we determined whether the increased
hepatic TAG content of mice maintained on these choline
restricted diets was attributable to impaired VLDL secretion by
quantifying serum TAG content after overnight-fasted mice had
been administered the lipoprotein lipase inhibitor tyloxapol.
Surprisingly, while all groups demonstrate significantly impaired
VLDL secretion relative to chow-fed control mice, no
differences among the four paste diet-fed cohorts were
observed (Figure 5).
Figure 7.  Relative hepatic mitochondrial genome content
in mice fed very low protein and carbohydrate, very high
fat diets.  Quantification of mitochondrial genome copy number
(relative abundance) by qPCR using purified liver gDNA from
mice maintained on the diets for 6 weeks. Data are presented
as means±SEM; n=4-5/group, *p≤0.05 by 1-way ANOVA with
Tukey’s post hoc testing.
doi: 10.1371/journal.pone.0074806.g007
Influence of dietary choline on mitochondrial structure,
number, and function in very low protein and
carbohydrate, very high fat diets
Among the paste diet cohorts, mice maintained on the VLP/C
+ and VLP/C- diets exhibited the greatest difference in
intrahepatic fat content, both histologically and biochemically,
despite similar VLDL secretion capacity and equal caloric
contents of protein, carbohydrate, and fat. Because adequate
choline content is essential for normal mitochondrial structure
and function in other macronutrient contexts [36–40], we
determined whether choline restriction in the VLP dietary
context was associated with abnormalities of mitochondrial
ultrastructure. As expected, transmission electron microscopy
of liver sections from chow-fed mice revealed that hepatocyte
mitochondria exhibit smooth outer and inner membranes with
tightly-organized cristae (Figure 6A-B). Most hepatocyte
mitochondria of VLP/C+-fed mice also exhibited normal
ultrastructure, although a small subset of hepatocyte
mitochondria lacked organized cristae (Figure 6C-D).
Moreover, sparse microvesicular lipid droplets were evident in
hepatocytes of VLP/C+-fed mice, a feature that was not
observed in hematoxylin and eosin-stained sections for light
microscopy. Unlike hepatocyte mitochondria in chow-fed and
VLP/C+-fed mice, all hepatocyte mitochondria of VLP/C--fed
mice exhibited swollen and disorganized cristae, and many
lacked definitive cristae entirely (Figure 6E–G). Additionally, the
spatial organization of mitochondria within the cytoplasm was
markedly disrupted by the presence of extensive lipid droplets
in hepatocytes of VLP/C--fed mice.
To further probe whether impairments in mitochondrial
function contribute to the extensive lipid accumulation observed
in mice fed the VLP/C- diet, we quantified the effects of choline
content in the VLP dietary contexts on hepatic mitochondrial
DNA content. Relative abundance of the mitochondrial genome
(mtDNA), normalized to the nuclear genome (nDNA) was
quantified by qPCR using isolated liver genomic DNA from
livers of chow-, VLP/C+, and VLP/C--fed mice. Primers targeting
mt-Atp6, mt-Cox1, mt-Cox3, and mt-Cytb were independently
employed as reporters of mtDNA relative abundance,
normalized against the nDNA gene Rpl32 (Figure 7). While
variation in the normalized mtDNA content was observed,
depending on the mtDNA gene quantified, livers of mice fed
both VLP/C+ and VLP/C- exhibited statistically significant
diminutions in mtDNA content, relative to chow-fed control
when using mt-Cox3 as a marker, with similar trends observed
using the other three mtDNA markers.
To determine if the marked diminution in hepatic lipid content
in VLP/C+-fed mice could be linked to alterations in
mitochondrial bioenergetics, mitochondria were isolated from
livers of mice maintained for 6 weeks on chow, VLP/C+, or
VLP/C- diets, and respiration studies were performed.
Substrates palmitoyl-L-carnitine + malate (which donate
electrons to Complexes I and II of the electron transport chain),
succinate + rotenone (rotenone is a Complex I inhibitor,
allowing electrons from succinate to be delivered exclusively to
Complex II), duroquinol (which selectively donates an electron
to Complex III), and TMPD (which selectively donates an
electron to Complex IV) + ascorbate (an antioxidant that
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Figure 8.  Respiration studies of hepatic mitochondria isolated from mice fed very low protein and carbohydrate, very high
fat diets.  (A) Respiration rates in the basal leak condition (state 2), ADP-stimulated condition (state 3), F1F0-ATPase independent
condition (state 4), and uncoupled condition in hepatic mitochondria isolated from chow-fed, VLP/C+-fed, and VLP/C--fed (for 6
weeks) mice using palmitoyl-L-carnitine and malate as substrates. n=4 mice/group. (B) Relative respiratory ratios of basal leak
(state 2/state 3), respiratory control (RCR, state 3/state 4), and coupling control (CCR, state 4/uncoupled), derived from panel A. (C)
Respiration rates in states 2-4 and while uncoupled in hepatic mitochondria isolated from chow-, VLP/C+, and VLP/C--fed mice that
respired using the Complex II-electron donor substrate succinate in the presence of rotenone (Complex I activity inhibitor). n=9
mice/group. (D) Relative respiratory ratios of state 2/state 3, state 3/state 4, and state 4/uncoupled, derived from panel C. (E)
Respiration rates in states 2-4 in hepatic mitochondria isolated from chow-, VLP/C+, and VLP/C--fed mice that respired using the
Complex III-donor substrate duroquinol plus rotenone. n=9 mice/group. (F) Relative respiratory ratios of state 2/state 3, state 3/state
4, and state 4/uncoupled, derived from panel E. (G) Respiration rates in states 2-4 in hepatic mitochondria isolated from chow-,
VLP/C+, and VLP/C--fed mice that respired using the Complex IV-donor substrate combination TMPD/ascorbate, plus rotenone. n=9
mice/group. (H) Relative respiratory ratios of state 2/state 3, state 3/state 4, and state 4/uncoupled, derived from panel G. Data are
presented as means±SEM. *p≤0.05; **p≤0.01 by 1-way ANOVA with Tukey’s post hoc testing.
doi: 10.1371/journal.pone.0074806.g008
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preserves TMPD’s reduced state) were independently used to
probe bioenergetic function.
Oxygen consumption in state 2 (basal proton leak) was
significantly increased in hepatic mitochondria isolated from
VPL/C--fed mice that were tested using palmitoyl-L-carnitine +
malate, compared to mitochondria prepared from livers of
chow-fed mice (Figure 8A). However, while trends toward
increased respiratory rates were observed, no significant
differences among state 3 (ADP-stimulated), state 4 (F1F0 ATP-
synthase inhibited), or uncoupled respiration (provoked by
addition of the ionophore FCCP) were observed among the
diets using palmitoyl-L-carnitine + malate as substrates (Figure
8A). Likewise there were no significant differences among the
ratios of states 2/3 (basal leak/stimulated ratio), 3/4
(Respiratory Control Ratio, RCR), or state 4/uncoupled
(Coupling Control Ratio, CCR) (Figure 8B). A trend toward
decreased CCR was observed in the VLP/C- group.
In the presence of succinate + rotenone, hepatic
mitochondria from VLP/C+-fed mice exhibited significantly
increased ADP-stimulated (state 3) oxygen consumption (Fig.
8C), which likely accounts for a significantly diminished relative
basal leak ratio (Fig. 8D), compared to chow-fed mice.
Figure 9.  Influence of choline restriction in integrated
hepatic mitochondrial fatty acyl-CoA metabolism.  Red text
and red arrows highlight hepatic processes known to be
impaired by administration of experimental choline deficient
diets. Unlike previous observations using lower fat choline
deficient versus replete formulations, in this study, choline
repletion in ~90% kcal fat diets did not alter triacylglycerol
(TAG) secretion as VLDL. However, choline restriction in a
~90% kcal fat diet was associated with mitochondrial structural
and functional abnormalities, which were linked to liver fat
accumulation and injury. CPT1, carnitine palmitoyltransferase
1; TCAC, tricarboxylic acid cycle; ETC, electron transport
chain; ATP, adenosine triphosphate.
doi: 10.1371/journal.pone.0074806.g009
Duroquinol-stimulated respiration revealed that Complex III-
associated basal leak and oligomycin-inhibited respiration were
increased selectively in hepatic mitochondria isolated from
VLP/C--fed mice (Fig. 8E-F). Finally, respiratory rates in
mitochondria stimulated with TMPD + ascorbate revealed that
hepatic mitochondria from VLP/C--fed mice exhibited significant
impairment in ADP-stimulated oxygen consumption, compared
to hepatic mitochondria from chow-fed control mice (Fig. 8G),
and consequently, significantly diminished RCR compared to
mitochondria from chow-fed animals (Fig. 8H). Using TMPD,
mitochondria from VLP/C--fed mice also exhibited a strong
trend toward decreased RCR, when compared to hepatic
mitochondria from VLP/C+-fed mice (p=0.06, n=9/group). Taken
together, these results indicate that choline restriction in the
setting of a high fat, very low carbohydrate diet contributes to
abnormal hepatic mitochondrial function, potentially impairing
terminal oxidation of fatty acids and contributing to hepatic TAG
accumulation. It is important to note that the deficiencies of
mitochondrial coupling and efficiency exhibited by isolated
hepatocyte mitochondria from VLP/C--fed mice likely
underestimate in vivo bioenergetic dysfunction, because an
enriched population of relatively intact mitochondria is assayed
using readily accessible experimental substrates. Therefore
integration of the mitochondrial structure and disordered spatial
organization with these respiration studies suggests
significantly impaired mitochondrial function in hepatocytes of
VLP/C--fed mice.
Discussion
The driver mechanisms for beneficial effects of low
carbohydrate ketogenic diets still remain to be elucidated, and
the prospective roles of these diets in preventing or
ameliorating human NAFLD are not defined. A commonly used
rodent high fat, and very low protein, very low carbohydrate
ketogenic diet, Bio-Serv F3666, has been employed to
measure the effects of the ketogenic nutrient milieu on
integrated metabolic homeostasis, and has also been used to
mitigate abnormal phenotypes in the nervous and
cardiovascular systems in mutant mouse strains. However, this
diet also induces hepatic steatosis, inflammation and
hepatocyte injury and repair in mice. To determine the
underlying nutritional determinants of these adverse effects, we
replicated this formulation by generating the VLP/C- diet, which
recapitulated the integrated metabolic and hepatic
histopathological responses to Bio-Serv F3666 in C57BL/6J
mice, and then tested three additional diets that systematically
varied protein and choline content in VLP/C-. We observed that
while protein and choline restriction synergistically contribute to
the integrated metabolic phenotypes provoked by a high fat,
very low carbohydrate diet in mice, choline restriction in this
setting stimulated hepatic fat accumulation to a greater extent
than protein restriction. Replenishment of choline in the VLP
diet (i.e., comparing VLP/C- to VLP/C+), markedly diminished
hepatic fat accumulation, while increasing dietary protein
content to 10% kcal in the setting of restricted choline
(comparing VLP/C- to LP/C-) exhibited a smaller mitigating
effect on hepatic steatosis. Adding protein to a choline-replete
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diet (comparing VLP/C+ to LP/C+) exerted marginal additional
effect on hepatic histopathology. While subtle variations were
evident in histopathological inflammation and in serological
evidence of hepatocellular injury (elevated ALT) among mice
maintained on the four paste diets, significant differences in the
hepatic density of F4/80+ macrophages after 6 weeks on the
diets were not observed. We previously demonstrated that
mice maintained on Bio-Serv F3666 (most similar to VLP/C-)
exhibit an increased density of hepatic F4/80+ macrophages
after 12 weeks on the diet [16]. Prolonged exposure to these
high fat diets likely exacerbates hepatic inflammation through
mechanisms summarized elsewhere [26]. Only VLP/C-, which
caused the greatest degree of fat accumulation, induced
histopathological evidence of hepatocyte regeneration at the 6
week time point, suggesting that this diet provokes the greatest
degree of hepatocellular injury. Taken together, these findings
suggest that inflammation and hepatocellular injury are likely
secondary to the extent and duration of the metabolic
abnormalities imposed by the nutrient contents.
Experiments in rodents have revealed molecular
underpinnings of liver fat accumulation using methionine and
choline deficient (MCD) diets [30,41], and diminished choline
intake has also been associated with a more aggressive
NAFLD course in humans [42]. The ability of experimental
MCD diets to trigger steatosis and liver injury is facilitated by
abundant mono- or disaccharides in the diet, because
replacing these simple carbohydrates with starch markedly
ameliorates the adverse histopathological effects of the MCD
diet, a portion of which is hypothesized to occur through
increased de novo lipogenesis [31,43]. Our results indicate that
choline restriction also triggers hepatic steatosis and
hepatocellular injury during a nutritional state in which the
mediators of de novo lipogenesis are transcriptionally silenced
due to very high fat content in the diet and diminished
circulating insulin concentrations. The metabolism of choline
has been mechanistically linked in mice to VLDL packaging
and secretion through its direct contribution to PC synthesis
[35]. Genetic models indicate that metabolic procession of
choline through the phosphatidylethanolamine (PE) N-
methyltransferase pathway, which synthesizes methionine from
homocysteine and choline-derived methyl groups, is also an
important contributor to VLDL secretion [35,44]. However, in
our experiments, while hepatic VLDL secretion was impaired in
mice maintained on all the paste diets, no additive effect of
choline restriction was observed in these macronutrient
contexts. It is therefore unlikely that an impairment of VLDL
secretion explains the marked fatty liver phenotype of VLP/C--
fed mice.
Mitochondrial dysfunction is a known contributor to NAFLD
pathogenesis [26,45]. Thus, we assessed hepatic
mitochondrial structure and function in mice fed these very high
fat diets. In mice maintained on VLP/C- diet, we observed
chaotic mitochondrial ultrastructure, including swollen cristae
and many degenerating mitochondria. Choline repletion in the
VLP diet was associated with improved mitochondrial
ultrastructure and respiratory coupling and capacity in isolated
mitochondria. However, choline repletion in the VLP diet did
not correct the reduction in mitochondrial DNA content.
Nonetheless, choline repletion may partially mitigate
mitochondrial dysfunction by contributing to PC synthesis. PC
is a major constituent of all cellular membranes, including
mitochondria [36,37]. Though the exact phospholipid
composition of membranes varies among experimental
contexts, PC and PE constitute approximately 40% and 30% of
the mitochondrial membranes, respectively [46]. Experimental
choline deficiency in lower fat diet formulations than those
tested here causes a decreased ratio of total hepatic PC/PE
[44,47–49] and hepatic mitochondrial dysfunction [38–40].
Furthermore, NAFLD patients have a reduction of the total
hepatic PC/PE ratio and impaired hepatocyte membrane
integrity [44,50]. Maintenance of mitochondrial function
requires homeostatic membrane phospholipid composition to
coordinate surface charge, stereoelectronic relationships, and
membrane dynamics that each effect membrane function and
structural integrity, critical determinants of mitochondrial
electron transport and oxidative phosphorylation [51–53].
Adaptation to a diet with ~90% kcal derived from fat requires
integration of hepatic mitochondrial fatty acyl-CoA transport,
esterification and storage in neutral pools, lipoprotein secretion,
and lipolysis, with mitochondrial β-oxidation, ketogenesis,
tricarboxylic acid (TCA) cycle, electron transport, and oxidative
phosphorylation (Figure 9), and impairment of hepatic
mitochondrial fatty acid oxidation contributes to liver fat
accumulation [54]. Effective procession of fatty acids through
integrated mitochondrial pathways also stimulates
gluconeogenesis [55,56]. Of the four paste diets tested,
however, only VLP/C--fed mice were not hyperglycemic.
Moreover, basal hepatic glucose production of mice maintained
on the VLP/C- parent diet Bio-Serv F3666 is normal, despite
delivering > 90% kcal as fat, and a poor hepatic suppressive
response to exogenous insulin [21]. A likely contributor to
relative hypoglycemia in VLP/C- and Bio-Serv F3666-fed mice
is hepatic mitochondrial dysfunction that prevents adequately
matched fatty acyl-CoA mitochondrial uptake and terminal
oxidation. Differences in extrahepatic glucose disposal could
also contribute to relative hypoglycemia in VLP/C- mice, but
glucose excursions among the four paste diets were not
significantly different (data not shown). Hyperglycemia in mice
fed LP/C-, despite steatosis and likely hepatic mitochondrial
dysfunction, is multifactorial but is most likely attributable to
additional dietary glucogenic amino acids that support
gluconeogenesis after conversion to TCA cycle intermediates.
Choline deficient diets provoke defects in carnitine
palmitoyltransferase (CPT 1) dependent fatty acyl-CoA
transport [57], palmitate oxidation [57], electron transport [58],
and as a result, gluconeogenesis [59,60] (Figure 9).
Conversely, ketogenesis is not directly impaired by choline
deficiency: both the fate-committing ketogenic enzyme,
mitochondrial hydroxymethylglutaryl-CoA synthase (HMGCS2),
and the enzyme catalyzing the subsequent ketogenic reaction,
hydroxymethylglutaryl-CoA lyase, are soluble mitochondrial
matrix enzymes that are influenced only indirectly by
dysfunctional mitochondrial membrane structure and function.
The results of these experiments strongly suggest that the
robust ketosis in VLP/C- mice reports the relative fraction of
fatty acyl-CoAs that successfully complete hepatic β-oxidation,
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and not those that fail to gain entry into mitochondria or those
that cannot complete terminal oxidation. Therefore, compared
to their choline restricted counterparts, ketosis was less
pronounced in mice fed the very high fat, choline replete diets
in part because integrated hepatic mitochondrial function
supports mitochondrial acyl-CoA uptake and terminal oxidation.
Conversely, relative suppression of ketosis in mice fed choline
restricted LP/C-, compared to mice fed VLP/C-, is attributable to
(i) the sensitivity in rodents to amino acid-mediated insulin
secretion [22,61], which in turn suppresses ketogenesis [62],
and (ii) the modest ability of amino acid-derived gluconeogenic
metabolites to suppress ketogenesis [63].
The independent contributions of choline and methionine
deficiencies to abnormal hepatic metabolism and pathology in
mice are incompletely understood because studies performed
heretofore suggest macronutrient context-dependent effects of
each of these micronutrients. In the context of carbohydrate-
enriched diets, selective choline deficiency drives hepatic
steatosis, while selective methionine deficiency has been
linked to hepatic inflammation, oxidative stress and
hepatocellular injury [64]. Conversely, mice fed a high fat (60%
kcal), 26% kcal carbohydrate diet are protected against hepatic
TAG accumulation, and do not exhibit overt inflammation or
hepatocellular injury by methionine restriction [65]. Because
thresholds for methionine deficiency-induced hepatocellular
injury are unknown and are highly dependent on macronutrient
distribution, these studies were not designed to definitively
segregate the independent roles of methionine and choline
restriction in the observed hepatic phenotypes. Nonetheless,
this study supports the supplementation of choline in rodent
experiments that are targeted to understand the physiological
adaptations and responses to diet-induced ketosis. These
experiments also demonstrate that nutritional induction of
ketosis by a very high fat, very low carbohydrate diet in mice
can occur in the context of maintained weight and
hyperglycemia. Therefore, experimental use of VLP/C+ diet
may allow mechanistic partitioning of the relative roles of
glycemia versus ketosis in experimental conditions that are
ameliorated by ketogenic diets.
An additional limitation of this study is that formal methods of
hepatic biometry and stereology were not used for
histopathological quantification of hepatocyte and fat droplet
sizes [66], and for histopathology, relatively small numbers of
animals were analyzed for each group. Nonetheless, hepatic
histopathological characteristics were highly uniform among
animals within each diet condition, and complementary formal
biochemical quantification of hepatic fat was performed in
larger numbers of animals. Moreover, effects of each of the five
diets studied were determined in at least three separate
cohorts of mice that were matched for age, strain, sex, and
body weight at the time of initiation of each of the study diets.
Analyses of histopathology, serum and hepatic biochemistry,
and mitochondrial function were performed among these
replicating cohorts to confirm reproducibility of the results.
Future experiments will incorporate formal histopathological
quantifications that reveal the mechanistic determinants
relating these nutritional states to hepatic lipid droplet size and
abundance.
In summary, these experiments demonstrate that the unique
signature of hepatic lipid accumulation, inflammation, and
cellular and mitochondrial injury induced in mice maintained on
a very high fat, protein-restricted, very low carbohydrate,
ketogenic diet can be linked to the adverse effects of choline
deficiency on hepatic mitochondrial structure and function. The
findings also underscore the concept that ketosis does not
necessarily report effective hepatic fatty acid oxidation when
supply overwhelms relative mitochondrial capacity. In setting of
the VLP/C- diet, ketogenesis provides a spill-over pathway that
only partially compensates for inadequate fatty acid catabolism.
However, it is important to note that while incompletely studied,
ketogenic diets in humans are unlikely to cause mitochondrial
dysfunction or fatty liver. Nonetheless, attentiveness to choline
content, and its downstream effects on membrane phospholipid
composition and function are important considerations when
designing and measuring the physiological effects of low
carbohydrate diets, which ultimately will require integration of
biochemical approaches to quantify compartment-specific
phospholipidomics with measurements of mitochondrial
function, biogenesis, and autophagic turnover.
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